Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Kezar Life Sciences (KZR) Interest Expenses (2021 - 2025)

Kezar Life Sciences (KZR) has disclosed Interest Expenses for 5 consecutive years, with $302000.0 as the latest value for Q2 2025.

  • Quarterly Interest Expenses fell 24.69% to $302000.0 in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $649000.0 through Dec 2025, down 59.26% year-over-year, with the annual reading at $1.6 million for FY2024, 2.77% up from the prior year.
  • Interest Expenses hit $302000.0 in Q2 2025 for Kezar Life Sciences, down from $347000.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $403000.0 in Q3 2024 to a low of $159000.0 in Q4 2021.
  • Historically, Interest Expenses has averaged $342400.0 across 5 years, with a median of $370000.0 in 2023.
  • Biggest five-year swings in Interest Expenses: soared 119.5% in 2022 and later fell 24.69% in 2025.
  • Year by year, Interest Expenses stood at $159000.0 in 2021, then soared by 119.5% to $349000.0 in 2022, then rose by 14.33% to $399000.0 in 2023, then fell by 2.51% to $389000.0 in 2024, then decreased by 22.37% to $302000.0 in 2025.
  • Business Quant data shows Interest Expenses for KZR at $302000.0 in Q2 2025, $347000.0 in Q1 2025, and $389000.0 in Q4 2024.